Endonovo Therapeutics (ENDV) Stock Chart & Stock Price History $0.0002 0.00 (0.00%) As of 08/1/2025 Add Compare Share Share Chart Stock AnalysisChartSEC FilingsShort InterestBuy This Stock Endonovo Therapeutics Stock Price Performance The Endonovo Therapeutics (ENDV) stock chart highlights key performance trends across multiple timeframes. Over the last 12 months, the stock's price has decreased 83.33%, with a year-to-date return of -50.00%. In the past month, the stock has increased 100.00%, reflecting recent market activity. As of the latest close, Endonovo Therapeutics traded at $0.00 with a market cap of $241 thousand and volume of 109,000 shares. Five years ago, the stock traded at $0.11, representing a 99.82% decrease over that period. At the time, it had a market cap of $105.37 million and a volume of 91,034 shares. Receive ENDV Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Endonovo Therapeutics and its competitors with MarketBeat's FREE daily newsletter. Email Address 5 Day Performance0.00%1 Month Performance+100.00%3 Month Performance+100.00%Year-To-Date Performance-50.00%1 Year Performance-83.33%5 Year Performance-99.82% ENDV Stock Chart for Sunday, August, 3, 2025 ENDV Chart by TradingView Endonovo Therapeutics Stock Price History Daily Weekly Monthly Yearly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 3 Year 5 Year Time Frame Start Date End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization08/01/2025$0.00$0.00$0.00$0.00109,000 shs$241,000.0007/31/2025$0.00$0.00$0.00$0.00109,000 shs$241,000.0007/30/2025$0.00$0.00$0.00$0.00328,164 shs$241,000.0007/29/2025$0.00$0.00$0.00$0.00606,044 shs$241,000.0007/28/2025$0.00$0.00$0.00$0.005.13 million shs$241,000.0007/25/2025$0.00$0.00+100.00%$0.00$0.0040.40 million shs$241,000.0007/24/2025$0.00$0.00$0.00$0.0047.90 million shs$121,000.0007/23/2025$0.00$0.00-66.67%$0.00$0.0050.17 million shs$121,000.0007/22/2025$0.00$0.00$0.00$0.001,500 shs$362,000.0007/21/2025$0.00$0.00+50.00%$0.00$0.00371,654 shs$362,000.00 Get the Latest News and Ratings for ENDV and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Endonovo Therapeutics and its competitors with MarketBeat's FREE daily newsletter. 07/18/2025$0.00$0.00$0.00$0.003.67 million shs$241,000.0007/17/2025$0.00$0.00+100.00%$0.00$0.001.25 million shs$241,000.0007/16/2025$0.00$0.00$0.00$0.001,500 shs$121,000.0007/15/2025$0.00$0.00$0.00$0.0050,600 shs$121,000.0007/14/2025$0.00$0.00-50.00%$0.00$0.0050,600 shs$121,000.0007/11/2025$0.00$0.00-33.33%$0.00$0.00179,233 shs$241,000.0007/10/2025$0.00$0.00+50.00%$0.00$0.00166,770 shs$362,000.0007/09/2025$0.00$0.00$0.00$0.0085,001 shs$241,000.0007/08/2025$0.00$0.00$0.00$0.0085,001 shs$241,000.0007/07/2025$0.00$0.00+100.00%$0.00$0.005.26 million shs$241,000.0007/04/2025$0.00$0.00$0.00$0.0010,030 shs$121,000.0007/03/2025$0.00$0.00-50.00%$0.00$0.0010,030 shs$121,000.0007/02/2025$0.00$0.00$0.00$0.001.03 million shs$241,000.00 Related Companies ARTH Stock Chart NIMU Stock Chart BIOL Stock Chart TTOO Stock Chart IONM Stock Chart HSDT Stock Chart INLB Stock Chart MAGAA Stock Chart SDCCQ Stock Chart GMVDF Stock Chart Receive ENDV Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Endonovo Therapeutics and its competitors with MarketBeat's FREE daily newsletter. This page (OTCMKTS:ENDV) was last updated on 8/3/2025 by MarketBeat.com Staff From Our PartnersMan Who Called Nvidia at $1.10 Says Buy This Now...In 2004, one man called Nvidia before just about anyone knew it existed. Now, this same guy says a new comp...The Oxford Club | SponsoredCrypto Income (almost instantly)How would you like to collect a small percentage of the $4 billion changing hands daily in the crypto market? ...Awesomely, LLC | SponsoredEx-Hedge Fund Manager Uncovers $100 Trillion Land ShiftTrump's Radical New Plan Could Enrich Thousands This isn't a campaign stunt. It's a $100 trillion move to u...Stansberry Research | SponsoredInvestigating the Most Controversial Stock on EarthTesla’s wild price swings may not be random after all. Hedge fund veteran Larry Benedict has uncovered a st...Brownstone Research | SponsoredThis New Rule Could Change EverythingA major change is quietly going into effect this July — and Wall Street is already positioning for it. Big ...American Alternative | SponsoredSell these "safe" blue chips immediatelyInvesting Legend Hints the End May be Near for These 3 Iconic Stocks One company to replace Amazon… another...InvestorPlace | SponsoredToo busy to trade? Good.Too busy to trade? That might be your edge. This after-hours strategy is built for people who don’t sit at ...Timothy Sykes | SponsoredREVEALED FREE: Our top 3 stocks to own in 2025 and beyondEvery time Weiss Ratings flashed green like this, the average gain on each and every stock has been 303% (incl...Weiss Ratings | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Endonovo Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Endonovo Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
